George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.10
Bid: 18.10
Ask: 19.00
Change: -0.35 (-1.90%)
Spread: 0.90 (4.972%)
Open: 18.10
High: 18.10
Low: 18.10
Prev. Close: 18.45
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV Estimate as at 31 December 2021

31 Jan 2022 07:00

RNS Number : 0606A
LMS Capital PLC
31 January 2022
 

 

 

 

 

 

 

 

 

 

31 January 2022

 

LMS CAPITAL PLC

NAV Estimate as at 31 December 2021

 

LMS Capital plc (the "Company") the listed investment company provides the following update and estimate of net asset value ("NAV") as at 31 December 2021.

 

Net Asset Value Estimate

 

The Company has commenced the year end valuation review process which is based on the latest performance updates from portfolio companies and third-party fund manager valuations.

 

The Board currently estimates that the year end NAV will be in the region of £49.1 million (60.8p per share). This NAV estimate, which represents an increase of £1.9 million (after adding back dividends paid) on the prior year, reflects information currently available to the Board on the performance and prospects of individual investments in the Company's portfolio and is subject to further evaluation as well as completion of the annual audit. The valuation methodology and policy adopted is consistent with prior years and is in line with IPEV guidelines.

 

The estimated 31 December 2021 NAV is summarised below:

 

Preliminary

31 December 2021 

 

Unaudited

30 June 2021

Audited

31 December 2020

£ 000s

MATURE ASSET PORTFOLIO

22,979

21,415

22,193

NEW INVESTMENTS - DACIAN

7,958

0

0

Total Investment Portfolio

30,937

21,415

22,193

Cash

20,113

21,372

20,591

Other Net Assets/Liabilities 

(1,949)

4,805

5,139

Net Asset Value

49,101

47,592

47,923

Pence per Share

60.8p

59.0p

59.4p

 

Overview

 

· The 31 December 2021 estimate of £49.1 million compares with £47.6 million being the unaudited NAV to 30 June 2021. NAV at the prior year end, 31 December 2020 was £47.9 million. Adjusting for £0.7 million dividends paid during the year, the NAV has increased by £1.9 million during the year.

 

· We are pleased to be issuing this NAV update having now completed the Dacian transaction, whereby the Company has acquired senior loans and equity in Dacian's business comprising onshore, late life, oil and gas production assets in Romania. The investment is structured as unsecured senior loans which carry a coupon of 14% per annum and a subscription for share capital for a nominal sum. The senior loans are expected to be repaid with interest over approximately 4 years. LMS holds $9.1 million of the 14% senior loans and 32% of the outstanding ordinary shares. 

 

· Some 15 months' interest income has been recognised on Dacian following that deal's completion in November 2021. This represents a pre-tax return of 18% in the year on the amount set side in September 2020 to pre-fund that investment. The Board expects the investment to meet or exceed the Company's medium-term return targets over its life.

 

· The unrealised gains shown during the year on the mature asset portfolio are in line with expectations. This portfolio is held in the expectation of realisation in a 1 to 3 year period.

 

· The Board is aware of the impact on overall returns of the Company's uninvested cash and is focussed on developing opportunities to deploy capital that will meet or exceed its target return of 12% to 15% per year.

 

· Running costs remain strictly controlled since the return to self-management. The Board expects to see a reduction in net running costs in the range of 5% to 10% in 2022 as the benefits of income from the Company's co-investment activities begin to be realised.

 

The Company will be issuing its full year end results in March and will provide a detailed update on the portfolio at that stage.

 

NAV changes

 

The NAV has increased by £2.2 million during the fourth quarter. Overall for the year as a whole, the Company's NAV, after adding back dividends paid, has increased by £1.9 million. The principal components of the full year increase are described below.

 

· Excluding the effect of foreign exchange rate changes, the mature asset portfolio showed a net unrealised gain of £2.6 million in the year, representing a return of 12% on the opening value of the portfolio. The principal elements were:

o An increase of £1.5 million in Brockton reflecting the unwinding of the discounted cash flows;

o An increase of £0.8 million in Weber Capital Partners, a US listed company fund;

o An increase of £0.4 million in the Opus Capital Venture Partners fund;

o An increase of £0.2 million in the value of Medhost;

o A decrease of £0.7 million in YesTo related to the winding up of the business. YesTo has been fully written off in the second half of 2021; and

o Other portfolio net gains were £0.4 million.

 

· Interest income of £1.2 million on the Dacian senior loans from September 2020 through the end of 2021. The Dacian investment was conditionally funded by investors in September 2020, pending completion. Completion occurred in November 2021 and under the terms of the Dacian investment agreement, once completion occurs, interest accrues to investors from the date of the original funding.

 

· Other movements were a net reduction of £1.9 million and include the following:

o Full year running costs were £1.8 million;

o Investment support costs (support costs for real estate and co-investment activities) were £0.3 million; and

o Unrealised foreign exchange gains of £0.2 million on non-portfolio assets, principally US Dollar bank accounts, due to the weakening of the US dollar against the sterling.

 

Further information on the performance of the portfolio, underlying investment valuations and changes during the year will be included in the Company's audited results for the year ended 31 December 2021, which it expects to announce in March 2022.

 

Outlook

 

The Company continues to have significant cash balances, £20.1 million at 31 December 2021 (31 December 2020: £20.6 million), and remains focussed on identifying opportunities to deploy capital in its areas of expertise - real estate, energy and late-stage private equity. Notwithstanding the impact and uncertainties around the Coronavirus pandemic, the Company made progress during 2021, particularly with the closing of the Dacian transaction in November 2021 and in building a pipeline of opportunities with its real estate industry partners. Further updates on the Company's portfolio will be included in the Company's final results announcement in March 2022.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please contact:

 

LMS Capital PLC

Nick Friedlos, Managing Director

0207 935 3555

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBMMLTMTJJBFT
Date   Source Headline
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23
23rd May 20234:03 pmRNSDividend Declaration - REPLACEMENT
18th May 20234:08 pmRNSDividend Declaration
18th May 20234:03 pmRNSResult of AGM
5th May 20237:00 amRNSStatement re Notice to shareholders
28th Apr 20237:00 amRNSFirst Quarter 2023 Update
24th Apr 20232:42 pmRNSNotice of AGM
24th Apr 20232:37 pmRNSNotice of AGM
14th Apr 202310:47 amRNSHolding(s) in Company
22nd Mar 20233:04 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSFinal Results fo rthe Year Ended 31 December 2022
7th Feb 20237:00 amRNSNet Asset Value(s)
25th Nov 20223:54 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSThird Quarter 2022 Update
2nd Aug 20227:09 amRNSHalf year Report and Dividend declaration
19th May 20223:42 pmRNSDividend Declaration
18th May 20224:27 pmRNSResult of AGM
27th Apr 20227:00 amRNSFirst Quarter 2022 Update
22nd Apr 20227:00 amRNSNotice of Annual General Meeting 2022
10th Mar 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
31st Jan 20227:00 amRNSNAV Estimate as at 31 December 2021
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSPortfolio Update
12th Nov 202112:34 pmRNSPortfolio Update
22nd Oct 20217:00 amRNSThird Quarter 2021 Update
23rd Sep 202112:16 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSDividend Declaration
3rd Aug 20217:00 amRNSHalf-year Report
8th Jul 202110:16 amRNSChange of Registered Office
18th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20213:32 pmRNSFinal Dividend for the year ended 31 December 2020
12th May 20214:20 pmRNSResult of AGM
29th Apr 20217:00 amRNSFirst Quarter 2021 Update
9th Apr 20217:00 amRNSAnnual Financial Report
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.